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Abstract
Background: Benign biliary strictures may be a consequence of surgical procedures, chronic
pancreatitis or iatrogenic injuries to the ampulla. Stents are increasingly being used for this
indication, however it is not completely clear which stent type should be preferred.
Methods: A systematic review on stent placement for benign extrahepatic biliary strictures was
performed after searching PubMed and EMBASE databases. Data were pooled and evaluated for
technical success, clinical success and complications.
Results: In total, 47 studies (1116 patients) on outcome of stent placement were identified. No
randomized controlled trials (RCTs), one non-randomized comparative studies and 46 case series
were found. Technical success was 98,9% for uncovered self-expandable metal stents (uSEMS),
94,8% for single plastic stents and 94,0% for multiple plastic stents. Overall clinical success rate was
highest for placement of multiple plastic stents (94,3%) followed by uSEMS (79,5%) and single plastic
stents (59.6%). Complications occurred more frequently with uSEMS (39.5%) compared with single
plastic stents (36.0%) and multiple plastic stents (20,3%).
Conclusion: Based on clinical success and risk of complications, placement of multiple plastic
stents is currently the best choice. The evolving role of cSEMS placement as a more patient friendly
and cost effective treatment for benign biliary strictures needs further elucidation. There is a need
for RCTs comparing different stent types for this indication.
Background
Benign biliary strictures occur most frequently as a conse-
quence of a surgical procedure of the gallbladder, mainly
cholecystectomy, or common bile duct (CBD) [1]. Other
causes include inflammatory conditions, such as chronic
pancreatitis and sclerosing cholangitis [2]. In addition,
cholelithiasis, sphincterotomy and infections of the bil-
iary tract may also lead to a stricture [3]. Benign strictures
of the biliary tract are associated with a broad spectrum of
signs and symptoms, ranging from subclinical disease
with mild elevation of liver enzymes to complete obstruc-
tion with jaundice, pruritus and cholangitis, and ulti-
mately biliary cirrhosis [4].
A bilio-digestive anastomosis, or a percutaneously or
endoscopically performed dilation with or without stent
placement are the most commonly used treatment
options for benign biliary strictures[5]. Stent placement in
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the CBD is an increasingly being used alternative to sur-
gery. Several reports on the nonsurgical management of
benign biliary strictures with stents have shown results
which are equal to those obtained by surgery [6-12]. The
endoscopic management typically consists of dilation and
insertion of one or more plastic stents followed by elective
stent exchange every 3 months to avoid cholangitis caused
by stent clogging [4,13]. An increasing number of plastic
stents will progressively dilate a stricture in the CBD or the
papilla. The major disadvantages of this method are the
need for multiple invasive procedures and the morbidity
caused by stent dysfunction resulting in recurrent jaundice
and cholangitis.
In malignant biliary strictures, uncovered self-expanding
metal stents (uSEMS) have been shown to have a longer
stent patency than plastic stents, mainly because of their
larger diameter [4,14]. Nonetheless, long-term stent pat-
ency is a limiting factor with uSEMS as well, as these
devices may obstruct due to epithelial hyperplasia and tis-
sue ingrowth through the stent meshes [15-17]. This proc-
ess of epithelial hyperplasia causes embedding of the stent
into the bile duct mucosa, making removal of uSEMS dif-
ficult or even impossible [18]. These drawbacks limit the
use of uSEMS in the treatment of benign biliary strictures.
Only limited data comparing the efficacy and safety of dif-
ferent biliary stent types for benign biliary strictures are
available. We therefore performed a systematic review of
the current literature to assess technical and clinical suc-
cess, and complications of different stent types for this
indication.
Methods
Systematic search
A systematic search of PubMed between January 1966 and
March 2008 and EMBASE between January 1980 and
March 2008 was performed. In PubMed, the MeSH head-
ings 'cholestasis' and 'obstructive jaundice' were used in
combination with the MeSH heading 'stent'. In EMBASE a
similar search using the same headings was performed.
We detected 1051 abstracts in PubMed and 476 abstracts
in EMBASE and these 1527 abstracts were evaluated. All
studies reporting on biliary stent placement in patients
with benign strictures were included. Non-English lan-
guage studies, letters, editorials, reviews, animal studies,
single case reports, studies with data on covered self-
expandable metal stents (cSEMS), studies with results on
intrahepatic strictures, studies with strictures of unknown
origin and studies in patients with malignant strictures or
children were excluded. This resulted in 51 abstracts being
retrieved as full text. Thirteen studies were excluded
because they were duplicates and 23 studies because they
contained no data on stent placement for benign biliary
strictures. Another 32 studies were added after manual
searching of references in the selected studies. Finally, 47
studies were retrieved for data extraction (Figure 1).
Data extraction
Data on study design, number of patients, etiology and
location of the stricture, route of stent placement, stent
type, follow-up time, previous treatment, median stenting
time, technical and clinical success rates, patency rate,
complications, stricture recurrence and mortality were
extracted.
Definitions
- Stenting time: the time between stent placement and
removal. Stenting time in patients treated with uSEMS was
defined as the time between stent placement and the
moment that further treatment was indicated because of
stent obstruction.
- Technical success: technically successful stent placement.
- Clinical success: no need for further treatment after stent
placement, relief of symptoms and/or significant decrease
in bilirubin level after stent placement.
- Complication: adverse event after stent placement, such
as cholangitis, pancreatitis, stent migration or hemor-
rhage.
- Mortality: procedure-related and stent-related death.
Statistics
The following data were pooled using a fixed effect model:
stenting time, technical success rate, clinical success rate,
complications and mortality. The number of patients with
a single plastic stent, multiple plastic stents and uSEMS
were plotted against clinical and technical success rates,
resulting in funnel plots, a statistical method used for
assessing publication bias [19]. If publication bias is not
present, a funnel plot is expected to be roughly symmetri-
cal. The underlying idea is that studies with the largest
number of patients estimate clinical and technical success
rates more accurately than studies with fewer patients. As
it may be difficult to establish publication bias by visual
inspection [20], we used the Mann-Whitney U test and
Spearman's rank correlation test to determine a correla-
tion between technical and clinical success rates per stent
type and the number of patients. A p-value < 0.05 was
considered statistically significant. SPSS software, version
15, (Inc., Chicago, Illinois, USA) was used to perform the
statistical analysis.
Results
Study types
From the 47 selected studies, data on outcome of biliary
stenting in 1116 patients were extracted (Table 1, 2). OfBMC Gastroenterology 2009, 9:96 http://www.biomedcentral.com/1471-230X/9/96
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Flowchart of search history on stents for benign extrahepatic biliary strictures Figure 1
Flowchart of search history on stents for benign extrahepatic biliary strictures.
1051 Pubmed/MEDLINE 
Total full text retrieval (51) 
Total full text retrieval (38) 
Total articles retrieved (70) 
No data on stents for benign 
strictrures (23) 
Total articles for data collection (47) 
Duplicates (13) 
 
Full text retrieval (35) 
 
Full text retrieval (16) 
Detected based on references (32) 
476 EMBASE 
987 excluded based on abstracts 
 
Reasons: for exclusion: 
- 13 animal studies 
- 191 non-English studies 
- 95 reviews 
- 58 letters 
- 30 editorials 
- 302 with inclusion of malignant cases 
- 85 single case reports 
- 199 other studies 
- 17 studies with intrahepatic strictures 
- 14 studies with children included 
- 10 studies with strictures of unknown origin 
- 2 studies with cSEMS 
451 excluded based on abstracts 
 
Reasons for exclusion: 
- 1 animal study 
- 1 non English study 
- 43 reviews 
- 22 letters 
- 19 editorials 
- 176 with inclusion of malignant cases 
- 40 single case reports 
- 138 other studies 
- 12 studies with children included 
- 6 studies with intrahepatic strictures 
- 2 studies with strictures of unknown origin BMC Gastroenterology 2009, 9:96 http://www.biomedcentral.com/1471-230X/9/96
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these, 24 studies reported on single plastic stents [2,21-
42], 6 on multiple plastic stents [43-48] and17 on uSEMS
[15,16,49-63]. A single plastic stent was compared with
multiple plastic stents in one non-randomized study [64].
The remaining studies were all case series, of which 33
were retrospective[16,21-29,31,35-37,39,41-44,47,49-
51,53-55,59,60,62,64] and 14 prospective in
design[15,30,32,34,38,40,45,48,52,56-58,61,63]
Patients
Fourty seven studies evaluated 786 patients treated with a
single plastic stent (7-11.5 Fr.), 148 with multiple plastic
stents (10-11.5 Fr.) and 182 with uSEMS.
Indications for stent placement included a biliary stricture
secondary to liver transplantation (n = 417, 37%), chronic
pancreatitis (n = 380, 34%), surgery (n = 170, 16%), and
other causes (n = 149,13%).
Most strictures were located in the CBD (47%), followed
by anastomotic strictures (40%), hilar strictures (11%)
and other locations (2%) (Table 3, 4).
In the majority of patients with chronic pancreatitis, a sin-
gle plastic stent was placed (85%), followed by uSEMS
(15%) and multiple plastic stents (0%). Similarly, single
plastic stents were placed in 82% of patients with a biliary
stricture after liver transplantation, followed by uSEMS
(22%) and multiple plastic stents (13%). In patients with
a biliary stricture after a surgical procedure uSEMS (50%)
were placed most frequently followed by multiple plastic
stents (35%) and a single plastic stent (15%).
Table 1: Case series with uncovered SEMS (uSEMS) for benign biliary strictures
Author Year N Age (years 
(range))
Women Intervention Route Etiology stricture Location 
obstruction
Prospective 
studies
Yamaguchi et al [63] 2006 8 median 65,7 (42-78) 0 Streckerstent (2) ERCP chronic pancreatitis CBD
O Brien et al [58] 1998 8 median 59 (26-88) unknown Wallstent ERCP postoperative/
endoscopic (5)
hilair (3)
chronic pancreatitis 
(2)
proximal (5)
idiopathic (1)
Deviere et al [15] 1994 20 mean 45 (27-61) 4 Wallstent ERCP chronic pancreatitis CBD
Mygind et al (75) 1993 2 unknown 2 Z stent PTC post operative CBD (1)
CBD and 
anastomosis (1)
Maccioni et al [56] 1992 18 mean 60 (22-76) 8 Z stent (17) PTC post operative anastomosis (13)
Wallstent (1) CBD (5)
Foerster et al [52] 1991 7 median 60 (49-80) 5 Wallstent ERCP (6) postoperative anastomosis (2)
PTC (1) CBD (5)
hepatoduodenal 
fistel (1)
Retrospective 
studies
van Berkel et al [62] 2004 13 mean 56 (40-79) 4 Wallstent ERCP chronic pancreatitis CBD
Roumilhac et al [60] 2003 12 unknown unknown Metal stent (12) ERCP post OLT anastomosis (11)
Eickhoff et al [51] 2003 6 median 38 (29-60) 1 Wallstent ERCP chronic pancreatitis CBD
Kahl et al [55] 2002 3 mean 48 (21-81) 1 Wallstent (3) ERCP chronic pancreatitis CBD
Bonnel et al [49] 1997 25 mean 64 (35-86) 13 Z stent PTC postoperative CBD (8)
anastomosis (17)
Rieber et al [59] 1996 8 mean 42 (17-66) 3 Palmaz stent PTC post OLT anastomosis (5)
nonanastomotis (3)
Hausegger et al [53] 1996 20 mean 62 (36-83) 7 Wallstent PTC chronic pancreatitis 
(7)
anastomosis (4)
fibrous papillary 
stenosis (2)
CBD (16)
psc (1)
post operative (10)
Chu et al [50] 1994 2 unknown unknown Z stent PTC post operative hilair (1)
CBD (1)
Ivancev et al [54] 1992 2 66 and 41 2 Z stent PTC post operative anastomosis (1)
CBD (1)
Rossi et al [16] 1990 17 mean 60 (22-76) 7 Z stent PTC postoperative anastomosis (13)
CBD (4)B
M
C
 
G
a
s
t
r
o
e
n
t
e
r
o
l
o
g
y
 
2
0
0
9
,
 
9
:
9
6
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
3
0
X
/
9
/
9
6
P
a
g
e
 
5
 
o
f
 
1
5
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
) Table 2: Case series with multiple plastic stents and single plastic stents for benign biliary strictures
Author Year N Age (years (range)) Women Intervention Route Etiology stricture Location obstruction
Prospective studies
Holt et al [32] 2007 53 48,5 (37-61) 32 single plastic stent ERCP post OLT anastomosis
Graziadei et al [30] 2006 84 53,5 21 single plastic stent ERCP post OLT anastomosis (65)
non anastomosis (19)
Pozsar et al [48] 2005 20 mean 61,3 (36-81) 18 multiple plastic stents ERCP post sphincterectomy distal CBD
Kuzela et al [45] 2005 43 mean 50,3 (37-82) 25 multiple plastic stents ERCP post operative hilair
Kahl et al [34] 2003 61 median 47 (21-81) 15 single plastic stent ERCP chronic pancreatitis (61) CBD
Tocchi et al [38] 2000 20 mean 57 10 single plastic stent ERCP post operative CBD (3)
hilair (17)
van Milligen et al [40] 1997 16 median 43 (17-69) 8 single plastic stent ERCP psc CBD (10)
hiliar (6)
Retrospective studies
Pasha et al [47] 2007 25 mean 46,7 (28-59) 4 multiple plastic stents ERCP post OLT anastomosis
Elmi et al [28] 2007 15 52 year (42-68) 9 single plastic stent ERCP post OLT anastomosis
Akay et al [21] 2006 11 42 (17-60) 6 single plastic stent ERCP post OLT anastomosis
Sharma et al [37] 2006 8 median 42 (20-61) 3 single plastic stent ERCP idiopathic CBD (6)
hilair (2)
Alazmi et al [22] 2006 143 unknown unknown single plastic stent ERCP post OLT anastomosis
Zoepf et al [42] 2005 7 median 55 (45-65) unknown single plastic stent ERCP post OLT anastomosis
Cahen et al [25] 2005 58 median 54 (19-85) 10 single plastic stent ERCP chronic pancreatitis CBD
Catalano et al [64] 2004 46 mean 48 (30-71) 11 1 plastic stent (34) ERCP chronic pancreatitis CBD
multiple plastic stents (12)
Morelli et al [46] 2003 25 mean 48 (18-72) 9 multiple plastic stents post OLT anastomosis
Hisatsune et al [31] 2003 19 45 (14-67) 9 single plastic stent ERCP post OLT anastomosis
Eickhoff et al [27] 2001 39 mean 54,7 (32-81) 7 single plastic stent ERCP chronic pancreatitis (39) CBD
Bourke et al [43] 2000 6 mean 53 (20-64) 3 multiple plastic stents ERCP post sphyncterectomy ampullary
Khandekar et al [44] 2000 17 median 50 (17-68) 13 multiple plastic stents ERCP post sphyncterectomy (10) CBD (14)
papillotomy (2) other (3)
post operative (3)
Vitale et al [41] 2000 25 mean 46,7 (36-89) 7 single plastic stent ERCP chronic pancreatitis CBD
Kiehne et al [35] 2000 14 (36-89) 2 single plastic stent chronic pancreatitis CBD
Farnbacher et al [29] 2000 31 50 (24-71) 3 single plastic stent ERCP chronic pancreatitis CBD
Rossi et al [36] 1998 15 mean 44 (28-55) 6 single plastic stent ERCP post OLT (15) anastomosis
De Masi et al [26] 1998 53 unknown unknown single plastic stent ERCP iatrogenic (39) CBD (20)
gallstones (8) hilair (30)
Aru et al [23] 1997 8 mean 44 7 single plastic stent ERCP post operative CBD (7)
hilair (1)
van Milligen et al [39] 1996 25 median 42 (21-74) 13 single plastic stent ERCP psc CBD (19)
hilair (3)
Itani et al [33] 1995 5 unknown unknown single plastic stent ERCP chronic pancreatitis CBD
Barthet et al [24] 1994 19 mean 49 1 single plastic stent ERCP chronic pancreatitis CBD
Deviere et al [2] 1990 25 mean 42 (34-69) 1 single plastic stent ERCP chronic pancreatitis CBDB
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Table 3: Results on route, previous treatment, treatment time, technical success, clinical success and complications in case series with uncovered SEMS (uSEMS) for benign 
biliary strictures
Author Intervention Follow up (range) Previous 
treatment
Technical success Clinical succes Treatment time 
Stentpatency
Total 
complications
Prospective 
studies
Yamaguchi et al [63] Streckerstent (2) > 5 years 
(7.4 year)
plastic stent 
placement
100% 62,50% unknown 25%
Wallstent (6)
O Brien et al [58] Wallstent mean 64,5 months (26-81) plastic stent 
placement (5)
100% unknown median 35 months (7-
57)
75
Tesdal et al [69] Wallstent (11) mean 63,8 months balloon dilatation (19) 100% unknown mean 30,2 months 64,50%
Palmazstent (9) median 80,5 
(2-116)
Streckerstent
(4)
Deviere et al [15] Wallstent mean 33 months (24-42) plastic stent 
placement (11)
100% 90% 3 and 6 months (2/20) 10
Mygind et al (75) Z stent 4 and 7 months balloon dilatation 100% 100% unknown unknown
Maccioni et al [56] Z stent (17) mean 37 months (30-41) percutaneous 
dilatation
83,30% 55,50% unknown 38,80%
Wallstent (1)
Foerster et al [52] Wallstent mean 32,7 weeks (21-53) laparotomy (2) 100% 100% 8 months until now 14%
Retrospective 
studies
van Berkel et al [62] Wall stent mean 50 months 
(6 d -86 months)
none 100% 69% 60 months 15,40%
Roumhilac et al [60] SEMS (12) median 37 months (18-53) plastic stent 
treatment for 1 year
100% 100% no stent obstruction unknown
Eickhoff et al [51] Wallstent median 58 months (22-29) plastic stent 
placement
100% unknown median 20 months 
(10-38)
83,40%B
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Kahl et al [55] Wallstent (3) median 37 months (18-53) plastic stent 
treatment for 1 year
100% 100% no stent obstruction unknown
Bonnel et al [49] Z stent mean 55 months (9-84) surgery (17) 18 one approach 72% 36%
T tube (8) 7 two approaches
Rieber et al [59] Palmaz stent mean 18 months (1,5-43) balloon dilatation 100% 62% occlusion
post PTBD occlussion time
1,5-2,5-24 months
Hausegger et al [53] Walsltent mean 31,2 months (3-78) balloon dilatation 100% unknown 73% (6 months) 50,00%
38% 
(36 months)
19% 
(end follow up)
3-3-3-4-5-11-24-2-36-
55
Chu et al [50] Z stent unknown plastic stents unknown 0%
PTBD
Ivancev et al [54] Z stent (2) 9 and 14 months balloon dilatation 100% 50% 50% (5 months) 50%
Rossi et al [16] Z stent mean 8 months (4-12) baloon dilatition 100% 82,40% unknown 11,80%
Table 3: Results on route, previous treatment, treatment time, technical success, clinical success and complications in case series with uncovered SEMS (uSEMS) for benign 
biliary strictures (Continued)B
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Table 4: Results on route, previous treatment, treatment time, technical success, clinical success and complications in case series with multiple plastic stents and single plastic 
stents for benign biliary strictures
Author Intervention Follow up (range) Previous 
treatment
Technical success Clinical succes Treatment time
Stentpatency
Total 
complications
Prospective 
studies
Holt et al [32] single plastic stent 18 months balloon dilatation 92% 69% 11,3 months 
(7-14)
69,70%
Graziadei et al [30] single plastic stent mean 39,8 
(0,3-98)
balloon dilatation unknown 77% anastomosis unknown 5-424 procedures
0% non anastomosis
Pozsar et al [48] multiple stent 
placement
mean 61,3 
(36-81)
dilatation unknown 90% median 9 months (3-
22)
37,70%
Kuzela et al [45] multiple stent 
placement
median 16 months (1-
42)
none 100% 100% 1 year 12%
after stent placement (planned)
Tocchi et al [38] single plastic stent mean 89,7 months none 100% 80% unknown 0%
Kahl et al [34] single plastic stent median 40 months 
(18-66)
none 100% 31,1% (1 year) 1 year (19) 34,40%
26,2% 
(40 months)
rest unknown
van Milligen et al [40] single plastic stent median 19 months (7-
27)
none 100% 81% median 9 days 7%
Retrospective 
studies
Pasha et al [47] multiple plastic stent median 21,5 months 
(5,4-31,2)
diliatation unknown 88% 
(intend to treat)
median 4,6 months 
(1,1-11,9)
27%
Elmi et al [28] single plastic stent 535 days 
(22-1301)
balloondilatation Unknown 87% 192 days 
(18-944)
22,2% (procedure)
sphincterectomy
Akay et al [21] single plastic stent 22 months 
(SD 13 months)
balloondilatation 75% 55% 3 months (6) 12%
6 months (1)
9 months (1)
12 months (3)
Sharma et al [37] single plastic stent median 19 months (4-
52)
balloondilatation 100% 100% median 19 months 18%
Alazmi et al [22] single plastic stent mean 28 months (1-
114)
balloondilatation 6,60% 82% unknown unknown
Zoepf et al [42] single plastic stent median 9,5 months 
(1-36)
sometimes dilatation 100% 85,60% median 8 months (2-
26)
18,60%
Cahen et al [25] single plastic stent median 45 months (0-
182)
sphincterectomy 100% 38% median 274 days (3-
2706)
52%
pancreatic duct 
stentingB
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Catalano et al [64] single plastic stent 
(34)
mean 4,2 years (1 
plastic stent)
unknown 100% 24% 1 stent 21 months 42,7% 
(single plastic stent)
multiple plastic stent 
(12)
mean 3,9 years 
(mulitple stents)
92% multiple stents 14 months 8,3% 
(multiple plastic stent)
Morelli et al [46] multiple plastic stent mean 54 weeks 
(5 wks - 103 mo)
diliatation 88% 90% unknown 3,70%
Hisatsune et al [34] single plastic stent mean 26 months(15-
44)
none 79% 93% mean 637 days (487-
933)
43%
Eickhoff et al [31] single plastic stent median 58 months (2-
146)
balloon dilatation 100% 31% mean 9 months (1-
144)
43%
nasobiliary drainage
Bourke et al [43] multiple plastic stent median 26,5 months 
(24-32)
dilatation unknown 100% median 12,5 months 33%
Author Intervention Follow up (range) Previous 
treatment
Technical success Clinical succes Treatment time
Stentpatency
Total 
complications
Khandekar et al [44] multiple plastic stent median 720 days sometimes dilatation Unknown 100% median 140 days (30-
1080)
unknown
Vitale et al [41] single plastic stent 32 months 
(13-76)
balloon dilatation Unknown 80% mean 13,3 months unknown
Khiene et al [35] single plastic stent 1-5 years none 100% 7,40% unknown 85,70%
Farnbacher et al [29] single plastic stent 24 months 
(2-76)
none 100% 13% 24 months 
(2-76 months)
72%
Rossi et al [36] single plastic stent 1 year dilatation 100% 83,30% 1 year 33,30%
De Masi et al [26] single plastic stent 6-84 months unknown Unknown 71,40% 24 months 52,70%
Aru et al [23] single plastic stent unknown unknown 100% 25% unknown unknown
van Millegen et al [39] single plastic stent mean 29 months (2-
120)
dilatation
nasobiliary drain
84% 76% 1 stent period (17) 30,5%
(procedure)
2 stent period (2)
3 stent period (3)
Itani et al [33] single plastic stent mean 7 months dilatation 100% 80% 4 months (2) unknown
1 change 4 months 
(2)
15 months (1)
Barthet et al [24] single plastic stent mean 18 months (13-
48)
none 100% 42% mean 10 months 10,50%
Deviere et al [2] single plastic stent mean 14 months (4-
72)
dilatation 100% 12% unknown 72%
Table 4: Results on route, previous treatment, treatment time, technical success, clinical success and complications in case series with multiple plastic stents and single plastic 
stents for benign biliary strictures (Continued)BMC Gastroenterology 2009, 9:96 http://www.biomedcentral.com/1471-230X/9/96
Page 10 of 15
(page number not for citation purposes)
Comparison between different stent types
The median stenting time was not different between mul-
tiple plastic stents (11.3 (range 4.6-13) months) and sin-
gle plastic stents (10.5 (0.3-24) months). Median stenting
time was 20 (4.5-60) months for uSEMS.
The technical success rate was not different between differ-
ent stent types (98,9% for uSEMS and 94.8% for single
plastic stents, 94.0% for multiple plastic stents) (Figure
2).
The clinical success rate for all patients was highest after
placement of multiple plastic stents (94,3%) followed by
uSEMS (79.5%) and single plastic stents (59,6%) (Figure
3). Clinical success rate in chronic pancreatitis patients
was highest for uSEMS (80.4%) and lowest for single plas-
tic stents (35.9%). Multiple plastic stents had the best
clinical performance for strictures following liver trans-
plantation (89.0%) and surgery (81.3%), whereas uSEMS
(69% and 62.3%, respectively) showed the worst clinical
results in these situations (Table 5).
Complications occurred most frequently with uSEMS
(39.5%), followed by a single plastic stent (36.0%) and
multiple plastic stents (20.3%) (Figure 4). The most fre-
quently reported complications included cholangitis,
pancreatitis, stent migration and hemorrhage.
No stent-related mortality was reported with placement of
multiple plastic stents, whereas 7 (0.9%) patients died as
a consequence of single plastic stent placement. Following
uSEMS placement, 2 (1.1%) patients died of a stent-
related cause. In all these cases, the cause of death was a
septic complication due to cholangitis.
Publication bias
Plotting the total number of patients with uSEMS against
technical and clinical success showed that publication
bias was not present (Figure 5). This was confirmed with
Spearman's rank correlation test for technical (r-0.218, p
= 0.435) and clinical success (r-0.089, p = 0.796) against
the number of included patients. The same was found
when technical success and clinical success rates in publi-
cations with ≤ 8 or >8 patients were compared (p = 0.414
and p = 0.779, respectively).
We also plotted the number of patients with a single plas-
tic stent against technical and clinical success and again
found no evidence of publication bias (Figure 6). Simi-
larly, no evidence of bias was found when the clinical suc-
cess in publications with ≤ 20 or >20 included patients
were compared (p = 0.065). For clinical success, this was
confirmed with Spearman's rank correlation test (r-0.343,
p = 0.109). For technical success, however, Spearman's
rank correlation test suggested publication bias (r-0.046,
p = 0.109). On the other hand, no evidence of bias was
Technical success of uncovered SEMS (uSEMS), multiple plas- tic stents and single plastic stents for benign biliary strictures Figure 2
Technical success of uncovered SEMS (uSEMS), mul-
tiple plastic stents and single plastic stents for benign 
biliary strictures.
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Clinical success of uncovered SEMS (uSEMS), multiple plastic  stents and single plastic stents for benign biliary strictures Figure 3
Clinical success of uncovered SEMS (uSEMS), multi-
ple plastic stents and single plastic stents for benign 
biliary strictures.
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found when publications with ≤ 20 or >20 patients were
compared (p = 0.303).
As the number of publications on multiple plastic stents
(n = 6) in benign biliary stricture was low, it was not pos-
sible to make funnel plots for this stent type.
Discussion
This review shows that the most optimal nonsurgical
treatment of benign extrahepatic biliary strictures has
been demonstrated with multiple plastic stent placement.
These results confirm that dilation with a large diameter
dilator, i.e. multiple plastic stents, for a prolonged period
is the most effective way to relieve benign strictures. It is
however important to note that these results were mainly
based on case series with often small patient numbers
included.
Complication rates were also lowest for multiple plastic
stents, followed by single plastic stents and uSEMS. The
low complication rate of multiple plastic stents is most
likely due to the practice of exchanging multiple plastic
Table 5: Overview of technical and clinical success of uncovered SEMS (uSEMS), multiple plastic stents and single plastic stents for 
benign biliary strictures
Single plastic 
stent
USEMS Multiple plastic 
stents
Technical 
success
Clinical success Technical 
success
Clinical success Technical success Clinical success
(mean) (mean) (mean) (mean) (mean) (mean)
All indications 94,10% 61.3% 98,50% 62,40% 97,60% 87,50%
Post operative 86,6,% 64,90% 97,60% 59,60% 100 87,60%
Chronic 
pancreatitis
100% 36,60% 100% 80,40% NA NA
Post OLT 97,20% 81% 100% 50% 88% 89%
Complications of uncovered SEMS (uSEMS), multiple plastic  stents and single plastic stents for benign biliary strictures Figure 4
Complications of uncovered SEMS (uSEMS), multi-
ple plastic stents and single plastic stents for benign 
biliary strictures.
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Numbers of patients with a benign biliary stricture vs.  reported results for technical success (a) and clinical success  (b) of uncovered self-expanding metal stent placement Figure 5
Numbers of patients with a benign biliary stricture 
vs. reported results for technical success (a) and clin-
ical success (b) of uncovered self-expanding metal 
stent placement.
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stents at 3-months intervals. This was found to be uncom-
mon after single plastic stent placement. In the latter,
cholangitis as a result of stent clogging occurred more fre-
quently. Due to their larger luminal diameter, placement
of uSEMS seems an attractive alternative for single or mul-
tiple plastic stents in benign biliary strictures, however
uSEMS have the disadvantage that tissue hyperplasia
through uncovered stent meshes may occur, leading to
stent obstruction [15,16,65]. Based on clinical success and
complication rates, placement of multiple plastic stents
has therefore still the best treatment profile for treatment
of benign biliary strictures.
Our findings are in line with results of stent placement for
specific causes of benign biliary obstruction, particularly
those following liver transplantation or a surgical proce-
dure. Only for patients with strictures due to chronic pan-
creatitis, uSEMS were found to give good results with
regard to clinical success. The number of studies that
included patients with this indication and were treated
with multiple plastic stents was low. The reason for this is
likely that biliary obstruction due to chronic pancreatitis
often has a protracted course, requiring multiple proce-
dures if plastic stents are used [66].
An exception to the overall poor results of endoscopic
treatment with single plastic stents in patients with
chronic pancreatitis was reported by Vitale et al. [41], who
achieved stricture resolution with single plastic stents in
80% of patients. Calcifications in the pancreatic head
were found in only 4 of 25 patients in this study, which
may well explain the high success rate. Calcifications in
the pancreatic head have been suggested to be a strong
predictor of failure of CBD stenting [34]. As these calcifi-
cations are often associated with a firm fibrotic compo-
nent due to the inflammatory reaction in chronic
pancreatitis [67], it can be expected that these strictures
are more difficult to dilate. Patients with chronic pancrea-
titis but without calcifications are more likely to have a
stricture secondary to edema and to have less pronounced
fibrosis. These strictures may subside over time and there-
fore only require temporary treatment. This explains why
single plastic stent placement for CBD strictures in this
patient category was found to be successful (78).
It should be noted that the disappointing results of uSEMS
placement, particularly in patients with biliary strictures
following liver transplantation or a surgical procedure, are
probably affected by selection bias. In most studies, the
included population consisted of patients in whom the
initial treatment, mostly plastic stent placement, had
already failed. As a consequence, these patients were prob-
ably more difficult to treat and less responsive to dilation.
We found that the median stenting time was not different
between multiple and single plastic stent placement (11.3
vs.10.5 months, respectively).uSEMS functioned clinically
well for a median time of 20 months (0.5-60) before a
reintervention, mostly for stent obstruction, was needed.
Reported reinterventions included placement of a new
stent within the occluded uSEMS, percutaneous biliary
drainage, endoscopic removal of sludge, or surgical or
endoscopic removal of the stent.
A problem with uSEMS is that they tend to embed into the
mucosa of the CBD, leading to mucosal hyperplasia. This
is an unwanted side effect, as removal of uSEMS in this sit-
uation is difficult, if not impossible. Removal may how-
ever be indicated when uSEMS are malpositioned or
obstructed, or have (partially) migrated [18,68]. Recently,
cSEMS have been introduced. These devices have the ben-
efit that removal is possible as the risk of embedding into
Numbers of patients with a benign biliary stricture vs.  reported results for technical success (a) and clinical success  (b) of single plastic stent placement Figure 6
Numbers of patients with a benign biliary stricture 
vs. reported results for technical success (a) and clin-
ical success (b) of single plastic stent placement.
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the biliary wall is reduced or even negligible. This capacity
combined with the larger diameter of cSEMS makes step-
wise dilation, as is performed with multiple plastic stents,
unnecessary and may thus reduce the number of proce-
dures [69]. The clinical experience with cSEMS for benign
biliary strictures is until now only limited [66,69,69].
cSEMS can achieve a luminal diameter that is comparable
to that of multiple plastic stents and uSEMS, but due to
their covering have the advantage that fewer procedures
for recurrent obstruction are required. In the future,
cSEMS are likely to be a more patient-friendly and cost-
effective treatment option for benign biliary strictures.
Until now, cSEMS placement for benign biliary strictures
is still associated with relatively high complication rates
(39.6%) [66,69,69]. In our opinion, new covered stents
and refinements of existing covered stents are needed
before large scale introduction of cSEMS for this indica-
tion can be recommended.
This review has several limitations which should be taken
into account before concluding that a particular stent type
is favorable in patients with a benign biliary stricture.
First, no randomized trials and only one comparative trial
have been conducted. This may be due to the fact that
(multiple) plastic stents have an acceptable technical and
clinical success rate in daily clinical practice. Moreover,
uSEMS placement has not been shown to be more suc-
cessful than multiple plastic stents in case series.
Secondly, several types of plastic stents were used in differ-
ent studies. Results on individual plastic stent types in
patients with benign biliary strictures are not available.
From trials in patients with malignant biliary strictures, it
is however known that different plastic stents types have
varying luminal patencies, due to the stent material and/
or the stent diameter [70-73]. Particularly, plastic stents
with a diameter of 10 French (Fr.) have been shown to be
remain patent for a significantly longer period than 8 Fr.
stents (median 32 vs. 12 weeks) [71].
Finally, there was a wide variety in treatment protocols in
the various studies with plastic stents. In some studies,
stent exchange was performed at 3-month intervals, while
in other studies stents were only exchanged when they
became occluded. Besides, the number of plastic stents
used for multiple stenting varied between 2 and 4 among
patients. This could both have affected clinical success
rates, but also complication rates in patients treated with
plastic stents.
The strength of this review is that all available data on the
use of plastic stents and SEMS for the treatment of biliary
strictures was evaluated. To the best of our knowledge,
this is the largest review on the use of different types of
stents in patients with a benign biliary stricture, with
pooled data on 1116 treated patients. We also showed
that the reported results, particularly those of single plas-
tic stents and uSEMS, were not affected by publication
bias, making an overestimation of the clinical success rate
and/or an underestimation of the complication rate of a
particular stent type unlikely.
Conclusion
In conclusion, this systematic review shows that, based on
clinical success and risk of complications, placement of
multiple plastic stents is currently the best choice. The
evolving role of cSEMS placement as a more patient
friendly and cost effective treatment for benign biliary
strictures needs further elucidation. There is a need for
RCTs comparing different stent types for this indication.
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